In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
|Podcasts|September 30, 2022
Tackling Specialty Conditions and Side Effects Simultaneously
Author(s)Nicholas Saraceno, Senior Editor
Ways to combat these ailments alongside worsening mental health
Advertisement
Carol Huynh, a practicing clinical pharmacist and manager of clinical outcomes at Shields Health Solutions, a specialty pharmacy accelerator, dissects the ways to address undertreated side effects that can form as a result of having a specialty condition, including the use of an adapted care model.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer's $2.2B Ohio Site
2
Why PhRMA Sued to Block Medicare's GLOBE Pricing Model
3
LogiPharma USA 2026: Data Readiness Must Come Before AI
4
Pharma Rethinks Supply Chain Planning as Disruptions Mount
5